FMO5 and chronic granulomatous disease: NADPH oxidase is also required in humans to prevent staphylococcal skin infection, since patients with chronic granulomatous disease (CGD) that have mutations in the NADPH oxidase NOX2 subunit show enhanced susceptibility to S. aureus skin infections [74].